Liu, Guangyang
Wang, Daohui
Jia, Jianru
Hao, Chunhua
Ge, Qinggang
Xu, Liqiang
Zhang, Chenliang
Li, Xin
Mi, Yi
Wang, Herui
Miao, Li
Chen, Yaoyao
Zhou, Jingwen
Xu, Xiaodan
Liu, Yongjun
Funding for this research was provided by:
Beijing Municipal Science and Technology Project (Z221100007922028, Z221100007922028, Z221100007922028, Z221100007922028, Z221100007922028, Z221100007922028, Z221100007922028, Z221100007922028, Z221100007922028, Z221100007922028, Z221100007922028, Z221100007922028)
Article History
Received: 4 March 2024
Revised: 10 July 2024
Accepted: 11 July 2024
First Online: 18 July 2024
Declarations
:
: The authors declare no conflicts of interest.
: All animals were maintained in SPF conditions and treated humanely. All experimental procedures involving animals were conducted by the national legislation and approved by the Laboratory Animal Ethics Committee, Yugen Pharmaceutical Technology Co., Ltd.